Are False Positive CAH Newborn Screens Common for Babies?
At a Glance
False-positive newborn screens for classic CAH are common because prematurity, low birth weight, illness, early testing, and screening methods can raise 17-OHP. A positive screen is not a diagnosis, but follow-up testing is needed because untreated CAH can cause dangerous salt and fluid loss.
Yes, false positive newborn screens for classic Congenital Adrenal Hyperplasia (CAH) are very common. While receiving a positive result can be incredibly frightening for parents, it is important to know that a screening test is a signal, not a diagnosis. The initial test simply flags babies who need further evaluation. Depending on the screening program’s methods, many—or even most—positive results turn out to be false positives [1][2].
However, because the test can also indicate a serious condition, every positive screen must be evaluated immediately.
Why Do False Positives Happen?
The standard newborn screen checks for classic CAH by measuring a hormone called 17-hydroxyprogesterone (17-OHP). This hormone builds up in the blood when the body lacks the enzyme needed to make cortisol. However, several normal or temporary factors can cause a healthy baby’s 17-OHP levels to be high:
- Prematurity and Low Birth Weight: Babies born early or small naturally have higher 17-OHP levels as part of their normal development [3][4].
- Physical Stress or Illness: Physical stress during a difficult delivery, birth asphyxia, or other neonatal illnesses can cause a temporary spike in 17-OHP [5][6].
- Testing Methods: The first-round test used by most states, called an immunoassay, sometimes cross-reacts with other harmless fetal hormones, mistakenly reading them as 17-OHP [7][8].
- Timing of the Test: A newborn’s 17-OHP levels are naturally high around the time of birth. If the heel-prick blood spot is collected early, it is more likely to trigger a positive result [9][10].
What Happens Next?
Even though false positives are common, doctors take every positive screen seriously. Untreated classic CAH can cause a salt-wasting crisis—a rapid loss of sodium and water that leads to dangerous dehydration and low blood pressure [9][11]. Because an infant may appear well before a crisis begins, a positive screen must always be followed up promptly [11].
To find out for sure whether your baby has CAH or if the screen was a false positive, your medical team will run confirmatory tests. Depending on your baby’s specific screening numbers, this evaluation may involve:
- A more precise second-step blood spot test (often called LC-MS/MS steroid profiling) that accurately separates 17-OHP from other normal fetal hormones [7][8].
- Urgent serum bloodwork drawn from a vein. This often includes testing 17-OHP, cortisol, and electrolytes (sodium and potassium) to see exactly how your baby’s adrenal glands are functioning right now [12][9]. Genetic testing is sometimes used later to help clarify the diagnosis, but it does not replace these immediate blood tests [13].
Follow your doctor’s explicit plan for testing and evaluation. Do not simply wait and monitor at home unless specifically instructed to do so by a pediatric specialist. Completing the follow-up testing promptly helps ensure timely diagnosis and treatment.
When to Seek Urgent Help
If you are waiting for follow-up appointments or confirmatory test results, you must monitor your baby closely. Go to the nearest emergency room immediately and tell them your baby had a positive newborn screen for CAH if you notice any of the following signs of a salt-wasting crisis:
- Repeated vomiting or an inability to keep feeds down
- Unusual sleepiness, lethargy, or unresponsiveness
- Limpness, weakness, or a seizure
- Signs of dehydration, such as significantly fewer wet diapers than normal
Common questions in this guide
How often is a positive CAH newborn screen a false alarm?
What can make a healthy newborn's CAH screen come back positive?
What tests confirm or rule out CAH after a positive screen?
What should I do if my baby has symptoms while waiting for CAH follow-up?
Does a positive newborn screen prove that my baby has classic CAH?
Related questions
Show more
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C, de Castro SM, Prado MJ, et al.
BMC pediatrics 2017; (17(1)):22 doi:10.1186/s12887-016-0772-x.
PMID: 28095810 - 2
Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.
de Hora MR, Heather NL, Webster DR, et al.
International journal of neonatal screening 2022; (8(4)) doi:10.3390/ijns8040056.
PMID: 36278626 - 3
Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
Yoon YA, Woo S, Kim MS, et al.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2023; (131(4)):216-221 doi:10.1055/a-2022-8399.
PMID: 36854385 - 4
17-hydroxiprogesterone values in healthy preterm infants.
Mendoza-Rojas VC, Díaz-Martínez LA, Mantilla-Mora G, et al.
Colombia medica (Cali, Colombia) 2017; (48(4)):161-166 doi:10.25100/cm.v43i4.2983.
PMID: 29662257 - 5
Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
Anandi VS, Shaila B
Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(6)):677-681.
PMID: 28489558 - 6
[UMBILICAL CORD CORTISOL LEVELS DO NOT CORRELATE WITH 17-HYDROXYPROGESTERONE LEVELS IN THE NEWBORN SCREENING TEST].
Weissmann R, Miller N, Litmanovitz I, Arnon S
Harefuah 2020; (159(10)):726-730.
PMID: 33103390 - 7
Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
Morejón García G, García de la Rosa I, González Reyes EC, et al.
Clinica chimica acta; international journal of clinical chemistry 2018; (485()):311-315 doi:10.1016/j.cca.2018.07.019.
PMID: 30006291 - 8
Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay.
Han L, Tavakoli NP, Morrissey M, et al.
Analytical and bioanalytical chemistry 2019; (411(2)):395-402 doi:10.1007/s00216-018-1449-0.
PMID: 30456606 - 9
Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Hormone research in paediatrics 2019; (91(6)):416-420 doi:10.1159/000501396.
PMID: 31450227 - 10
The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
Jiang X, Tang F, Feng Y, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(11)):1253-1258.
PMID: 31603856 - 11
Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening.
Banaszak-Ziemska M, Małecka E, Łacna K, et al.
Pediatric endocrinology, diabetes, and metabolism 2021; (27(4)):291-297 doi:10.5114/pedm.2021.109123.
PMID: 35114771 - 12
Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.
Lai F, Srinivasan S, Wiley V
International journal of neonatal screening 2020; (6(3)):63 doi:10.3390/ijns6030063.
PMID: 33117905 - 13
Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Choi JH, Kim GH, Yoo HW
Annals of pediatric endocrinology & metabolism 2016; (21(1)):1-6 doi:10.6065/apem.2016.21.1.1.
PMID: 27104172
This information about a positive CAH newborn screen is for education only and is not medical advice. Follow your newborn screening team's instructions promptly, and seek emergency care if your baby develops concerning symptoms.